CDH1 and hepatocellular carcinoma: The combination therapy most significantly inhibited the EMT of HCC cells than the monotherapies, as manifested by the highest expression of E-cadherin and the lowest expression of N-cadherin, Snail, and vimentin (P-values < 0.05).